1216 Reg QT

BioCentury & Getty Images

Dec. 16 Quick Takes: MacroGenics' margetuximab approved for breast cancer; plus sotorasib, Mesoblast, Cardior, Takeda, Allero

By Jeff Cranmer, Executive Editor

Dec 17, 2020 | 2:40 AM GMT

First approval for MacroGenics
FDA approved Margenza margetuximab-cmkb

Read the full 387 word article

How to gain access

Continue reading with a
two-week free trial.